actate Dehydrogenase (LDH) as a Tumor Marker for Non-small Cell Lung Cancer
Young Jin Yuh, Sung Rok Kim
Cancer Res Treat. 2002;34(5):339-344.   Published online 2002 Oct 31     DOI: https://doi.org/10.4143/crt.2002.34.5.339
Citations to this article as recorded by Crossref logo
Nomogram combining clinical and radiological characteristics for predicting the malignant probability of solitary pulmonary nodules measuring ‚ȧ 2 cm
Mengchao Xue, Rongyang Li, Kun Wang, Wen Liu, Junjie Liu, Zhenyi Li, Zheng Ma, Huiying Zhang, Hui Tian, Yu Tian
Frontiers in Oncology.2023;[Epub]     CrossRef
Serum lactate dehydrogenase activities as systems biomarkers for 48 types of human diseases
Yuling Wu, Caixia Lu, Nana Pan, Meng Zhang, Yi An, Mengyuan Xu, Lijuan Zhang, Yachong Guo, Lijuan Tan
Scientific Reports.2021;[Epub]     CrossRef
Nedaplatin as a Single-Agent Chemotherapy May Support Palliative Therapy for Patients with Adenoid Cystic Carcinoma: A Case Report
Hiroyuki Hirakawa, Takayoshi Kiba, Yuko Saito, Yoshiteru Watanabe, Takahiro  Suzuki, Nobuo Ota
Case Reports in Oncology.2017; 10(2): 783.     CrossRef
Tumor Lysis Syndrome Induced by Radiotherapy in Non-Small Cell Lung Cancer
Dong-Hyo Noh, Ki-Eun Hwang, Jeong-Hyun Shin, Dong Kim, Kyung-Hwa Cho, Keum-Ha Choi, Seong-Hoon Park, Eun-Taik Jeong, Hak-Ryul Kim
Journal of Lung Cancer.2010; 9(2): 106.     CrossRef